Relationship Details
Connected Entities
Evidence
The F.D.A. reprimanded Celgene multiple times and held a meeting to warn the company about its marketing practices for Thalomid.
The F.D.A. reprimanded Celgene multiple times and held a meeting to warn the company about its marketing practices for Thalomid.
The F.D.A. reprimanded Celgene multiple times and held a meeting to warn the company about its marketing practices for Thalomid.
Source Documents (1)
HOUSE_OVERSIGHT_028418.jpg
This document is a digital article, labeled for a House Oversight investigation, concerning the pharmaceutical company Celgene and its executive, Mr. Hugin. It details the company's aggressive marketing of the drug Thalomid for unapproved uses shortly after its launch, leading to multiple reprimands from the F.D.A. in the late 1990s and a whistle-blower lawsuit settled in 2017. The document is not related to Jeffrey Epstein.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein relationship